Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (5): 702-708.doi: 10.12092/j.issn.1009-2501.2025.05.015

Previous Articles     Next Articles

The NO-sGC-cGMP pathway and heart failure

LI Dilu, PEI Yuanyuan, WANG Wuchao, CAO Lingjie, YANG Fengtao, SHI Shuangkui, ZHOU Guyue, YANG Kunyu, ZHU Jihong   

  1. Department of Emergency, Peking University People's Hospital, Beijing 100044, China
  • Received:2024-08-20 Revised:2024-10-11 Online:2025-05-26 Published:2025-05-13

Abstract:

Heart failure, as a global public health challenge, is experiencing an increasingly severe disease burden. Given the close relationship between the Nitric Oxide-Soluble Guanylate Cyclase-Cyclic Guanosine Monophosphate (NO-sGC-cGMP) signaling pathway and heart failure, this study, through a comprehensive search and review of recent literature on the NO-sGC-cGMP pathway and heart failure, aims to outline the mechanism of action of this signaling pathway and its connection with heart failure, in order to explore new avenues for the treatment of heart failure.

Key words: heart failure, signaling pathway, nitric oxide, soluble guanylate cyclase, cyclophosphate guanylate

CLC Number: